AP19679620
Проводит National Scientific Center of Traumatology and Orthopedics named after academician N.D. Batpenov
Страница компанииDevelopment of Biomedical Technology for the Treatment of Ankle Cartilage Using Injectable Biocomposite Hydrogel
Источник: ClinicalTrials.gov (U.S. National Library of Medicine). Что откуда
Простыми словами
Словарь терминов- Статус исследования в реестре не указан — уточняйте в центре.
- Возраст участников: 18–65 лет. Остальные условия — в блоке «Кто может участвовать».
- По плану участвуют 40 чел. во всех странах исследования.
- Плановая дата окончания (11.2025) уже прошла.
Пересказ собран автоматически из данных реестра, без оценки пользы и рисков. Подробно о рисках и пользе рассказывает врач центра перед подписанием согласия.
Кто может участвовать
Полный текст критериев (на английском, как в ClinicalTrials.gov) · включение: 3 · невключение: 11
Критерии включения
- patients with a local defect of articular cartilage of the talus bone (Outerbridge II-IV) of the ankle joint;
- an area of no more than 3 cm2 for a single defect or 20 cm2 for multiple defects of the cartilaginous tissue of the talus bone of the ankle joint;
- voluntary consent to participate in the study.
Критерии невключения
- age 18< and >65
- progressive osteoarthritis of the ankle joint in the late stages;
- synovitis of the ankle joint;
- instability of the ankle joint;
- BMI<29.9;
- presence of non-sanitized foci of chronic infection;
- severe mental illnesses (schizophrenia, psycho-organic syndrome);
- hormonal osteopathy;
- hemiparesis on the side of the proposed operation;
- neoplasms of other localizations with or without metastases;
- absence (refusal) of voluntary consent to participate in the study.
Источник: ClinicalTrials.gov, NCT06028763 · запись обновлена в реестре 29 ноября 2023.
Дизайн и результаты
Что измеряют — первичные конечные точки (2), вторичных — 3
- The American Orthopedic Foot and Ankle Score — 6; 12 months after surgery
- Visual Analogue Scale — 6; 12 months after surgery
Цель исследования
This study aims to evaluate the effectiveness of heparin-conjugated gel for treating ankle joint cartilage lesions compared to the conventional microfracture method. It involves 40 participants aged 18 to 65 with localized cartilage defects (Outerbridge II-IV) in the ankle's talus bone.
Participants will be divided into two groups: the main group and the control group. The main group will undergo a two-stage process. Initially, adipose tissue will be collected via lipoaspiration from osteoarthritis patients. This tissue will be used to isolate mesenchymal stem cells (MSCs) and extract growth factors, resulting in a biocomposite hydrogel. In the second stage, arthroscopy will be performed to apply the hydrogel for cartilage treatment.
The control group will undergo standard microfracture surgery, a known cartilage repair method.
The study's main objective is to compare heparin-conjugated gel treatment to microfracture in terms of cartilage repair and patient outcomes. A 12-month follow-up will assess short-term and potential mid-term effects.
Data will be analyzed using Microsoft Excel and Statistica 13.0 for descriptive and comprehensive statistical analysis. Quantitative indicators will be assessed using appropriate tests (Mann-Whitney, Wilcoxon T, χ2) to determine significant differences between groups.
The study addresses key questions: Does heparin-conjugated gel offer better cartilage repair, functional improvement, and pain reduction than microfracture? Does the hydrogel approach better preserve joint integrity and slow degeneration? Are there complications with either method? This study combines cellular and surgical components to explore innovative cartilage lesion treatments. Comparing with microfracture and using a thorough follow-up, it aims to enhance cartilage repair techniques and patient outcomes.
Где проходит
0 центровЦентры в реестре не указаны.
Откуда эта информация
-
ClinicalTrials.gov (U.S. National Library of Medicine) · NCT06028763 Официальный реестр (США) · загружено 9 ноября 2026Номер протокола, название, цель, сроки, число участников, спонсор
Сведения сведены и нормализованы порталом «Клиномир»: названия компаний и центров приведены к одному написанию. Нашли ошибку? Напишите нам — исправим.